Structure, heterogeneity and developability assessment of therapeutic antibodies, fusion proteins and ADCs
Tuesday, November 3, 2020 10:00 AM to 10:20 AM · 20 min. (Africa/Abidjan)
European Antibody Congress
CMC & developability
Presentation
Information
- Critical quality attributes ranking (CQAs)
- FDA & EMA approved biologics benchmarking
- Multi-dimensional analytical methods
Alain Beck, Senior Director, Biologics CMC and Developability, Pierre Fabre, Associate Editor, mAbs
Documents & Links
Slides